Dr.Reddys Laboratories reported INR9B in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Aspen Pharmacare ZAR 12.34B 739M Jun/2024
Bharat Petroleum INR 5.58B 98.38B Mar/2025
Cipla INR 8B 1.22B Mar/2025
Dr.Reddys Laboratories INR 9B 5.65B Jun/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
UPL INR 95.37B 56.27B Mar/2025